TIMP-1 protects the human breast carcinoma cell line MCF-7 S1 against antracycline-induced cell death by activation of the akt survival pathway

Sidse Ørnbjerg Würtz, Anne-Sofie Schrohl Rasmussen, Nils Brunner, Ulrik Axel Lademann

    Fingerprint

    Dive into the research topics of 'TIMP-1 protects the human breast carcinoma cell line MCF-7 S1 against antracycline-induced cell death by activation of the akt survival pathway'. Together they form a unique fingerprint.

    Medicine & Life Sciences